Kevin D. Bunker - Chief Scientific Officer at Zentalis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
ZNTL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin D. Bunker since 14 Mar 2025

Holdings reported by Kevin D. Bunker for Zentalis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 834,931 $8,591,106 $10.29 20 Dec 2023 Direct
Common Stock 15,000 $154,344 $10.29 20 Dec 2023 Indirect
Common Stock 350 $3,601 $10.29 20 Dec 2023 As UTMA custodian for sons

Transactions reported by Kevin D. Bunker for Zentalis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.